POZ July/August 2025
POZ July/August 2025
In every issue of POZ, you’ll find the latest health news, personal stories and much more.
Also Available On:
Features
Speaking Out for Justice
In an excerpt from her new book, longtime activist Mary Fisher speaks truth to power and shares wisdom from decades of HIV advocacy.
What’s in the Pipeline for HIV?
Researchers are working on longer-acting therapies for HIV treatment.
Village Apothecary Continues to Go Above and Beyond
The pharmacy has served people living with HIV since 1983. Many long-term survivors say they’ll never go elsewhere.
2025 HIV Drug Chart
This quick-reference chart compares antiretroviral options for the treatment of HIV, including adult dosing information.
Editor’s Letter
Love is the Drug
For folks with HIV, especially in the early days of AIDS, their lives often literally depended on the caring staff at independent pharmacies
POZ Q&A
Centering Aging With HIV
NMAC argues for a greater focus on the needs of older people living with HIV.
POZ Planet
Bodies and Coffins to Protest HIV Cuts
The symbolic die-ins and caskets represent the deaths to come.
Chicago HIV Groups Mark Milestones
Howard Brown Health and AIDS Foundation Chicago hosted galas to celebrate.
R.I.P. Michael Siever, PhD
The HIV activist, harm reduction advocate and psychologist was 74.
My Mom Is a Warrior and My Hero
Erica Lavina is fortunate to have her mom by her side
Everyday – July/August 2025
These dates represent milestones in the HIV epidemic. Visit poz.com/aidsiseveryday to learn more about the history of HIV and AIDS.
Voices
Thank You, Dr. Greg
In an article titled “When Shawn and Gwenn Met Dr. Greg,” POZ contributing writer Shawn Decker thanked his longtime HIV physician.
Spotlight
Advocates in Action
Three events varying in scale and focus showcased the dedication and optimism that have been hallmarks of the HIV community since the 1980s.
Nutrition & Fitness
Peach Sweet Tea Granita
A little lemon juice enhances the peachy taste.
Reduce Your Health Risks
Regular physical activity can lower blood pressure, improve your cholesterol levels and more.
Basics
Clinical Trials
Medical studies are the key to advances in HIV prevention, treatment and cure research.
Research Notes
Prevention: New PEP Options
The new guidelines emphasize the importance of starting PEP within 24 hours of exposure if possible.
Treatment: Doravirine/Islatravir
A once-daily combination pill maintained viral suppression for a year in a pair of Phase III trials.
Cure: T-Cell Engager
In a Phase I/II STRIVE trial, IMC-M113V, an experimental bispecific T-cell engager, was generally safe and well tolerated.
Concerns: Cardiovascular Risk
Associations between BMI, excess abdominal fat and cardiovascular disease risk in people with viral suppression on antiretrovirals
Care & Treatment
Funding Cuts Could Increase HIV Cases
This could be just the tip of the iceberg.
Can HIV Treatment Lower Cancer Risk?
Cancer is a growing concern as the HIV population ages.
Gender-Affirming Care Linked to Better HIV Outcomes
In recent years, researchers have made progress in understanding outcomes among trans people living with or at risk for HIV.
Expanding Access to Long-Acting Injectables
Cabenuva is administered by a health care provider once monthly or every other month.
Heroes
Helping People Live
MANNA, a Philadelphia-based nonprofit, feeds chronically ill people in the city and surrounding counties.
Digital Edition
POZ July/August 2025
Read the digital edition.
